How evidence-based medicine is failing due to biased trials and selective publication

[1]  A. Nierenberg,et al.  Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. , 2005, The American journal of psychiatry.

[2]  B. Knishkowy,et al.  The association between funding by commercial interests and study outcome in randomized controlled drug trials. , 2001, Family practice.

[3]  S. Chimonas,et al.  Exposing conflict of interest in psychiatry: does transparency matter? , 2012, International journal of law and psychiatry.

[4]  J. Tanne.  US judge fines Johnson & Johnson $1.1bn for misleading marketing of risperidone , 2012, BMJ : British Medical Journal.

[5]  Thomas A Trikalinos,et al.  The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey , 2007, Canadian Medical Association Journal.

[6]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[7]  S. Shott,et al.  Association Between Funding Source and Study Outcome in Orthopaedic Research , 2003, Clinical orthopaedics and related research.

[8]  D. Altman,et al.  Assessing Risk of Bias in Included Studies , 2008 .

[9]  C. Gross,et al.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.

[10]  B. Djulbegovic,et al.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review , 2003, BMJ : British Medical Journal.

[11]  D B Matchar,et al.  What role do neurologists play in determining the costs and outcomes of stroke patients? , 1996, Stroke.

[12]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[13]  Blair T. Johnson,et al.  Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.

[14]  Daniel L. Sahling.  Pediatric Bipolar Disorder: Underdiagnosed or Fiction? , 2009, Ethical Human Psychology and Psychiatry.

[15]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[16]  Sharon E Straus,et al.  Evidence-Based Medicine: How to Practice and Teach It , 2010 .

[17]  L. Hranov,et al.  Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial , 2008, The Lancet.

[18]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[19]  J. Lacasse,et al.  Ghostwriting at Elite Academic Medical Centers in the United States , 2010, PLoS medicine.

[20]  J. Lenzer.  Manufacturer admits increase in suicidal behaviour in patients taking paroxetine , 2006, BMJ : British Medical Journal.

[21]  K. Martin,et al.  Postmenopausal hormone-replacement therapy. , 2001, The New England journal of medicine.

[22]  J. Brown.  Politics, Method, and Medical Research , 2008, Philosophy of Science.

[23]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[24]  J. Sterne,et al.  Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. , 2000, Journal of clinical epidemiology.

[25]  E. Walters,et al.  What is evidence-based medicine and the role of the systematic review: the revolution coming your way. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[26]  James Le Fanu,et al.  The Rise and Fall of Modern Medicine , 1999 .

[27]  Z. Kmietowicz.  Johnson & Johnson to pay $2.2bn to settle charges of false marketing on three drugs , 2013, BMJ.

[28]  Peter C Gøtzsche,et al.  Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review , 2006, BMJ : British Medical Journal.

[29]  Heidi D Nelson,et al.  Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.

[30]  D. Sackett,et al.  Evidence based medicine: what it is and what it isn't , 1996, BMJ.

[31]  D. Zuckerman.  Hype in Health Reporting: “Checkbook Science” Buys Distortion of Medical News , 2003, International journal of health services : planning, administration, evaluation.

[32]  B. Roehr.  Professor files complaint of scientific misconduct over allegation of ghostwriting , 2011, BMJ : British Medical Journal.

[33]  A. Zimerman.  Evidence-based medicine: a short history of a modern medical movement. , 2013, The virtual mentor : VM.

[34]  Harlan M. Krumholz,et al.  Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis , 2009, PLoS medicine.

[35]  Peter B. Jones,et al.  Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). , 2006, Archives of general psychiatry.

[36]  F. Song,et al.  Dissemination and publication of research findings: an updated review of related biases. , 2010, Health technology assessment.

[37]  Tsuguya Fukui,et al.  Systematic Evaluation and Comparison of Statistical Tests for Publication Bias , 2005, Journal of epidemiology.

[38]  R. McLean,et al.  Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. , 2008, The Journal of clinical psychiatry.

[39]  J. Ioannidis,et al.  Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.

[40]  J. Lieberman,et al.  Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. , 2006, The American journal of psychiatry.

[41]  B. Roehr.  GlaxoSmithKline is fined record $3bn in US , 2012, BMJ : British Medical Journal.

[42]  R. DeRubeis,et al.  Antidepressant drug effects and depression severity: a patient-level meta-analysis. , 2010, JAMA.

[43]  C. Elliott.  White Coat, Black Hat: Adventures on the Dark Side of Medicine , 2010 .

[44]  Q. Gu,et al.  Antidepressant use in persons aged 12 and over: United States, 2005-2008. , 2011, NCHS data brief.

[45]  R. Haynes,et al.  What kind of evidence is it that Evidence-Based Medicine advocates want health care providers and consumers to pay attention to? , 2002, BMC health services research.

[46]  I. Olkin,et al.  The case of the misleading funnel plot , 2006, BMJ : British Medical Journal.

[47]  Stefan Leucht,et al.  Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. , 2006, The American journal of psychiatry.

[48]  J. Ioannidis,et al.  Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? , 2008, Philosophy, ethics, and humanities in medicine : PEHM.

[49]  J. Ioannidis,et al.  Persistence of contradicted claims in the literature. , 2007, JAMA.

[50]  M Egger,et al.  Are randomised controlled trials in the BMJ different? , 2001, BMJ : British Medical Journal.

[51]  J. Howick,et al.  Philosophy of Evidence-Based Medicine , 2011 .

[52]  Richard Smith,et al.  Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies , 2005, PLoS medicine.